| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/25/2014 | US20140288034 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 09/25/2014 | US20140288033 Crystalline forms of a biphenyl compound |
| 09/25/2014 | US20140288032 Agents and devices for use in prevention of restenosis |
| 09/25/2014 | US20140288029 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine |
| 09/25/2014 | US20140288017 Catechol diethers as potent anti-hiv agents |
| 09/25/2014 | US20140288001 Kallikrein inhibitors and anti-thrombolytic agents and uses thereof |
| 09/25/2014 | US20140287991 Hepatitis B Virus-Binding Polypeptides and Methods of Use Thereof |
| 09/25/2014 | US20140287990 Compositions and methods to concurrently treat and/or prevent multiple diseases with cupredoxins |
| 09/25/2014 | US20140287983 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis |
| 09/25/2014 | US20140287064 Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument |
| 09/25/2014 | US20140287058 Composition for maintaining bone health and for treating osteoarthritis and osteoarthrosis of the joints |
| 09/25/2014 | US20140287051 Orally administered corticosteroid compositions |
| 09/25/2014 | US20140287048 Paste comprising non-steroidal anti-inflammatory drug |
| 09/25/2014 | US20140287047 Nanoemulsion therapeutic compositions and methods of using the same |
| 09/25/2014 | US20140287032 Treatment Method and Product for Uterine Fibroids using Purified Collagenase |
| 09/25/2014 | US20140287030 Antileishmanial compositions and methods of use |
| 09/25/2014 | US20140287027 Vesicle-encapsulated corticosteroids for the treatment of cancer |
| 09/25/2014 | US20140287022 Liposomal formulations |
| 09/25/2014 | US20140287006 Degradation-Stabilised, Biocompatible Collagen Matrices |
| 09/25/2014 | US20140287002 Agonists Of Guanylate Cyclase And Their Uses |
| 09/25/2014 | US20140287001 Compositions Useful For The Treatment Of Gastrointestinal Disorders |
| 09/25/2014 | US20140286981 Broadly reactive mosaic peptide for influenza vaccine |
| 09/25/2014 | US20140286960 Staphlococcus aureus alpha-hemolysin antibodies |
| 09/25/2014 | US20140286955 Notch agonists for the treatment of cancer |
| 09/25/2014 | US20140286943 Cyclopropyl modulators of p2y12 receptor |
| 09/25/2014 | US20140286938 Spiroketals |
| 09/25/2014 | US20140286932 Giant Obscurins and Uses Thereof in Cancer Prognosis and Therapy |
| 09/25/2014 | US20140286931 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor |
| 09/25/2014 | US20140286927 Method for the treatment of ulcerative colitis in patients refractory to steroid therapy using leached ligand fibrin stabilizing composition |
| 09/25/2014 | US20140286903 Substituted Purine Nucleosides, Phosphoramidate and Phosphordiamidate Derivatives for Treatment if Viral Infections |
| 09/25/2014 | US20140286902 Combination therapy of hsp90 inhibitors with platinum-containing agents |
| 09/25/2014 | US20140286900 2'-branched nucleosides and flaviviridae mutation |
| 09/25/2014 | US20140286899 Inhibitors of hepatitis c virus |
| 09/25/2014 | US20140286891 Ion binding polymers and uses thereof |
| 09/25/2014 | US20140286873 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 09/25/2014 | US20140286870 Rapid infusion of autologous bone marrow derived stem cells |
| 09/25/2014 | US20140286869 Rapid infusion of autologous bone marrow derived stem cells |
| 09/25/2014 | US20140286861 RS7 Antibodies |
| 09/24/2014 | EP2781516A2 New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid |
| 09/24/2014 | EP2781225A1 Intestinal fibrosis treatment agent |
| 09/24/2014 | EP2780017A1 Combination of a phosphoinositide 3-kinase inhibitor and a modulator of the janus kinase 2-signal transducer and activator of transcription 5 pathway |
| 09/24/2014 | EP2780008A1 Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof |
| 09/23/2014 | US8841450 Compounds useful as inhibitors of ATR kinase |
| 09/23/2014 | US8841417 IL-1 binding proteins |
| 09/23/2014 | US8841351 Polymeric topical compositions |
| 09/23/2014 | US8841346 Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders |
| 09/23/2014 | US8841331 Inhibitors of human immunodeficiency virus replication |
| 09/23/2014 | US8841329 Nicotinic attenuation of CNS inflammation and autoimmunity |
| 09/23/2014 | US8841309 Substituted pyrazines and their use in the treatment of disease |
| 09/23/2014 | US8841302 HCV inhibitor and therapeutic agent combinations |
| 09/23/2014 | US8841300 Treatment for Parkinson's disease—combination high dose serotonergic synaptic reuptake inhibitor with phosphodiesterase inhibitor |
| 09/23/2014 | US8841294 Active ingredient combinations having insecticidal and acaricidal properties |
| 09/23/2014 | US8841279 Oligo-guluronate and galacturonate compositions |
| 09/23/2014 | US8841277 Methods for treating non-small cell lung cancer using 5-azacytidine |
| 09/23/2014 | US8841258 Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation |
| 09/23/2014 | US8841255 Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides |
| 09/23/2014 | US8841100 Use of methylsulfonylmethane (MSM) to modulate microbial activity |
| 09/23/2014 | US8841067 NOL3 is a predictor of patient outcome |
| 09/23/2014 | US8840930 Pharmaceutical composition for inhalation |
| 09/23/2014 | US8840912 Imidazole derivatives useful for controlling microbial growth |
| 09/23/2014 | US8840908 Vaccine composition containing synthetic adjuvant |
| 09/23/2014 | US8840906 Methods and compositions related to immunizing against Staphylococcal lung disease and conditions |
| 09/23/2014 | US8840899 Use of mTOR inhibitors to enhance T cell immune responses |
| 09/23/2014 | US8840891 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 09/23/2014 | US8840886 Method of treating cancer with DLL4 antagonist and chemotherapeutic agent |
| 09/23/2014 | US8840883 Metallo-protein and tocotrienol (MP-T3) compositions with non-protein-type metal chelator and uses thereof |
| 09/23/2014 | US8840880 Canine probiotic bifidobacteria globosum |
| 09/23/2014 | US8840878 Peptidomimetic sulfamide compounds and antiviral uses thereof |
| 09/23/2014 | US8840867 Embolizing sclerosing hydrogel |
| 09/23/2014 | CA2632544C Use of myostatin antagonist for treating the effects of hypogonadism |
| 09/23/2014 | CA2441815C Method and composition for treatment of skeletal dysplasias |
| 09/18/2014 | WO2014144850A1 Methods of treating cancer and preventing cancer drug resistance |
| 09/18/2014 | WO2014144487A1 System and method of sending pci express data over ethernet connection |
| 09/18/2014 | WO2014143855A2 Combination cancer treatments utilizing micrornas and egfr-tki inhibitors |
| 09/18/2014 | WO2014143835A1 Combination/adjuvant therapy for wt-1-positive disease |
| 09/18/2014 | WO2014143669A1 Compositions for use in treating heavy menstrual bleeding and uterine fibroids |
| 09/18/2014 | WO2014143591A1 Inhibition of neovascularization by simultaneous inhibition of prostanoid ip and ep4 receptors |
| 09/18/2014 | WO2014143471A1 Oral electrolyte solution containing lactoferrin and uses thereof |
| 09/18/2014 | WO2014142660A1 Combinations of inhibitors of mek, egfr and erbb2 in the treatment of kras-mutant lung cancer and kras-mutant colon cancer |
| 09/18/2014 | WO2014141135A1 Respirable agglomerates of porous carrier particles and micronized drug |
| 09/18/2014 | WO2014140312A1 Flavonoid-based composition for pharmaceutical, nutritional or cosmetic use having potentiated antioxidant action |
| 09/18/2014 | WO2014140284A1 Use of linagliptin in cardio- and renoprotective antidiabetic therapy |
| 09/18/2014 | WO2014139894A1 Homoarginine as therapeutic for the reduction of myocardial remodeling |
| 09/18/2014 | WO2014138999A1 Methods for the diagnosis and treatment of inflammatory bowel disease |
| 09/18/2014 | WO2014138793A1 A method of isolating cells for therapy and prophylaxis |
| 09/18/2014 | US20140276493 Wound healing compositions |
| 09/18/2014 | US20140276363 Sonochemical Induction of ABCA1 Expression and Compositions Therefor |
| 09/18/2014 | US20140275711 1-(Arylmethyl)-5,6,7,8-tetrahydroquinazolline-2,4-diones and Analogs and the Use Thereof |
| 09/18/2014 | US20140275479 Specific binding agents of human angiopoeitin-2 |
| 09/18/2014 | US20140275295 Method for treating type i and type ii diabetes |
| 09/18/2014 | US20140275279 Cysteamine in the treatment of fibrotic disease |
| 09/18/2014 | US20140275257 N-acetyl cysteine compositions in the treatment of systemic lupus erythematosus |
| 09/18/2014 | US20140275246 Racecadotril lipid compositions |
| 09/18/2014 | US20140275245 Bicyclic analgesic compounds |
| 09/18/2014 | US20140275234 Compositions and methods of using crystalline forms of wortmannin analogs |
| 09/18/2014 | US20140275225 Modulators of pharmacological agents |
| 09/18/2014 | US20140275223 MicroRNA-BASED APPROACH TO TREATING MALIGNANT PLEURAL MESOTHELIOMA |
| 09/18/2014 | US20140275220 THE miRNA-212/132 FAMILY AS A THERAPEUTIC TARGET |
| 09/18/2014 | US20140275201 Identification of cancer stem cell markers and use of inhibitors thereof to treat cancer |
| 09/18/2014 | US20140275175 Organic compounds |